COSTAMAGNA, GIANLUCA
COSTAMAGNA, GIANLUCA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer
2025 M.C. Kielkopf, J. Göcmen, S.B. Venzin, F. Steinauer, M. Branca, A. Boronylo, M.B. Göldlin, J. Kaesmacher, A. Mujanovic, G. Costamagna, T.R. Meinel, D.J. Seiffge, P. Bücke, M.R. Heldner, A.L. Liberman, H. Kamel, U. Fischer, M. Arnold, T. Pabst, M.D. Berger, S. Jung, A. Scutelnic, B.B. Navi, M. Beyeler
Anticoagulant or antiplatelet therapy in patients with cancer and ischemic stroke and clinical outcomes
2025 G. Costamagna, A. Hottinger, D. Strambo, F. Livio, B. Navi, P. Michel
Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics and microbiomics
2025 S. Scarcella, L. Brambilla, L. Quetti, M. Rizzuti, V. Melzi, N. Galli, L. Sali, G. Costamagna, G.P. Comi, S. Corti, D. Gagliardi
Initiating or Resuming Cancer Treatment after Ischemic Stroke and Clinical Outcomes
2025 G. Costamagna, A.F. Hottinger, D. Strambo, F. Livio, B.B. Navi, P. Michel
Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
2024 B.B. Navi, C. Zhang, B. Miller, M. Cushman, S.E. Kasner, M.S.V. Elkind, D.L. Tirschwell, W.T. Longstreth, R.A. Kronmal, M. Beyeler, J. Elm, R.M. Zweifler, J. Tarsia, C.W. Cereda, G. Bianco, G. Costamagna, P. Michel, J.P. Broderick, D.J. Gladstone, H. Kamel, C. Streib
Qualitative assessment of thrombus permeability: Patients’, histopathological, radiological characteristics and outcomes
2024 M. Meneri, L. Caschera, G. Lopez, G. Platania, C. Luisa Bianchi, S. Bonato, G. Costamagna
Acute ischaemic stroke in active cancer versus non-cancer patients: stroke characteristics, mechanisms and clinical outcomes
2024 G. Costamagna, A.F. Hottinger, H. Milionis, A. Salerno, D. Strambo, F. Livio, B.B. Navi, P. Michel
Mortality in acute ischemic stroke patients with new cancer diagnosed during the index hospitalization versus after discharge
2024 J. Gocmen, F. Steinauer, M. Kielkopf, M. Branca, C.C. Kurmann, A. Mujanovic, L. Clenin, N. Silimon, A. Boronylo, A. Scutelnic, T. Meinel, J. Kaesmacher, P. Bucke, D. Seiffge, G. Costamagna, P. Michel, U. Fischer, M. Arnold, B.B. Navi, T. Pabst, M.D. Berger, S. Jung, M. Beyeler
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment
2024 G. Costamagna, B.B. Navi, M. Beyeler, A.F. Hottinger, L. Alberio, P. Michel
Advancing Stroke Research on Cerebral Thrombi with Omic Technologies
2023 G. Costamagna, S. Bonato, S. Corti, M. Meneri
IV Thrombolysis With or Without Endovascular Treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors
2023 K. Seystahl, N. Martinez-Majander, A. Salerno, M. Beyeler, H. Erdur, J.P. Marto, C. Hametner, M. Zedde, A. Pezzini, R. Leker, V. Altersberger, G. Costamagna, M. Serodio, L. Migliaccio, R. Pascarella, A. Zini, L. Mannismaki, Y. Bejot, S. Jung, H. Gensicke, V. Padjen, P.A. Ringleb, C. Nolte, M.R. Heldner, P. Michel, S.T. Engelter, S. Curtze, M. Weller, S. Wegener
Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer
2023 G. Costamagna, A. Hottinger, H. Milionis, D. Lambrou, A. Salerno, D. Strambo, F. Livio, B.B. Navi, P. Michel
Genomic and transcriptomic advances in amyotrophic lateral sclerosis
2023 M. Rizzuti, L. Sali, V. Melzi, S. Scarcella, G. Costamagna, L. Ottoboni, L. Quetti, L. Brambilla, D. Papadimitriou, F. Verde, A. Ratti, N. Ticozzi, G.P. Comi, S. Corti, D. Gagliardi
Intravenous thrombolysis with or without endovascular treatment for suspected ischemic stroke in patients with intracranial tumors
2023 K. Seystahl, N. Martinez-Majander, A. Salerno, M. Beyeler, H. Erdur, J.P. Marto, C. Hametner, M. Zedde, A. Pezzini, R.R. Leker, V.L. Altersberger, G. Costamagna, M. Serôdio, L. Migliaccio, R. Pascarella, A. Zini, L. Razaqi, Y. Béjot, S. Jung, H. Gensicke, V. Padjen, P. Ringleb, C.H. Nolte, M.R. Heldner, P. Michel, S.T. Engelter, S. Wegener, M. Weller
A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β+-Thalassaemia Patient
2022 M. Bortolotti, G. Costamagna, D. Gagliardi, M.M. De Amicis, N. Bresolin, G. Graziadei
Bridging the Gap : Gene Therapy in a Spinal Muscular Atrophy Type 1 Patient
2022 G. Costamagna, A. Govoni, A. Wise, S. Corti
Newly Diagnosed Hepatic Encephalopathy Presenting as Non-convulsive Status Epilepticus: A Case Report and Literature Review
2022 M. Olivero, D. Gagliardi, G. Costamagna, D. Velardo, F. Magri, F. Triulzi, G. Conte, G.P. Comi, S. Corti, M. Meneri
Human spinal cord-like organoids to model C9ORF72 ALS and test new therapies in vitro
2021 G. Costamagna, N. Galli, M. Rizzuti, B. Frizzi, F. Biella, M. Taiana, S. Ghezzi, I. Faravelli, G.P. Comi, M. Nizzardo, S. Corti
C9orf72 ALS Human Neural Organoids for the Development of New Therapeutics and Disease Modeling
2021 G. Costamagna, F. Biella, I. Faravelli, M. Nizzardo, R. Brusa, G.P. Comi, N. Bresolin, S.P. Corti
Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
2021 D. Gagliardi, G. Costamagna, E. Abati, E. Mauri, R. Brusa, L. Scudeller, L. Andreoli, G. Citterio, E. Piccin, F. Magri, M. Meneri, D. Velardo, M. Sciacco, N. Bresolin, S. Corti, G.P. Comi